0001354488-13-002288.txt : 20130429 0001354488-13-002288.hdr.sgml : 20130427 20130429172334 ACCESSION NUMBER: 0001354488-13-002288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051231 FILED AS OF DATE: 20130429 DATE AS OF CHANGE: 20130429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIRSCHWEILER THOMAS CENTRAL INDEX KEY: 0001273547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 13793247 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 issuerdirect_section16.xml PRIMARY DOCUMENT X0306 4 2005-12-31 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001273547 GIRSCHWEILER THOMAS C/O BIOLIFE SOLUTIONS, INC. 3303 MONTE VILLA PARKWAY BOTHELL WA 98021 1 1 Common Shares 2005-12-31 4 P 0 1761827 0.12 A 2299887 D Common Shares 2006-05-01 4 P 0 479999 0.06 A 13989886 D Common Shares 2007-02-13 4 J 0 416666 0 A 14406552 D Common Share Warrants 0.07 2010-11-29 4 J 0 1000000 0 A 2010-11-29 2015-11-29 Common Shares 1000000 1000000 D Common Share Warrants 0.063 2011-08-10 4 J 0 1000000 0 A 2011-08-10 2016-08-30 Common Shares 1000000 1000000 D Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on December 31, 2005 closing price of Issuer?s common shares. Resulting purchase from cash dividend paid to Series G preferred stockholders; purchase price based on May 1, 2006 closing price of Issuer's common shares. Total includes 11,210,000 common shares acquired upon conversion of Series F and Series G preferred shares and warrants previously reported on Form 4 filed on April 18, 2006 and 538,060 common shares previously held. Shares of common stock issued to reporting person in connection with financing costs related to Secured Multi-Draw Term Loan Facility Agreement in the amount of $2,000,000, with a maturity date of January 11, 2010. Warrants acquired as consideration for an amendment to the issuer's Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person's "Facility?" to $4,750,000 and extending the maturity date to January 11, 2013. Warrants acquired as consideration for an amendment to the issuer's Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person's "Facility"? to $5,250,000. /s/ Thomas Girschweiler 2013-04-29